Biotech ends summer on a high

Biotech finished on a high in August, according to San Francisco venture capital firm Burrill & Company.

The company’s Burrill Biotech Select Index closed up 4.4 percent on Friday before the Labor Day holiday weekend, said G. Steven Burrill, company CEO.

Top performers included Emeryville’s Onyx Pharmaceuticals (ONXX), up 42 percent, and Vertex Pharmaceuticals, up 21 percent.

Just Posted

City to double rate of bike rack installation

Bike racks are about to spring up across The City like wildflowers.… Continue reading

School district leaders want to keep cops off campus

SFUSD renegotiating agreement with police on handling of incidents involving students

Large fire displaces residents in Castro District

A large fire in San Francisco’s Castro District Saturday morning injured two… Continue reading

CCSF faces further class cuts to stem $13 million deficit

College weighing elimination of some programs including culinary arts, journalism

Confusion over planning codes nearly kills Sunset District restaurant project

A San Francisco couple that dreamed of serving the community they live… Continue reading

Most Read